| Age of onset of schizophrenia: perspectives from structural neuroimaging studies N Gogtay, NS Vyas, R Testa, SJ Wood, C Pantelis Schizophrenia bulletin 37 (3), 504-513, 2011 | 395 | 2011 |
| A diffusion tensor imaging study of white matter in early-onset schizophrenia M Kyriakopoulos, NS Vyas, GJ Barker, XA Chitnis, S Frangou Biological psychiatry 63 (5), 519-523, 2008 | 174 | 2008 |
| Effect of age at onset of schizophrenia on white matter abnormalities M Kyriakopoulos, R Perez-Iglesias, JB Woolley, RAA Kanaan, NS Vyas, ... The British Journal of Psychiatry 195 (4), 346-353, 2009 | 97 | 2009 |
| The Maudsley early onset schizophrenia study: predictors of psychosocial outcome at 4-year follow-up NS Vyas, M Hadjulis, A Vourdas, P Byrne, S Frangou European child & adolescent psychiatry 16, 465-470, 2007 | 89 | 2007 |
| Neurobiology and phenotypic expression in early onset schizophrenia NS Vyas, NH Patel, BK Puri Early intervention in psychiatry 5 (1), 3-14, 2011 | 82 | 2011 |
| Positron emission tomography in schizophrenia: a new perspective NH Patel, NS Vyas, BK Puri, KS Nijran, A Al-Nahhas Journal of Nuclear Medicine 51 (4), 511-520, 2010 | 81 | 2010 |
| Youth services: meeting the mental health needs of adolescents NS Vyas, M Birchwood, SP Singh Irish Journal of Psychological Medicine 32 (1), 13-19, 2015 | 43 | 2015 |
| Deficits in visual sustained attention differentiate genetic liability and disease expression for schizophrenia from bipolar disorder CTS Kumar, T Christodoulou, NS Vyas, M Kyriakopoulos, R Corrigall, ... Schizophrenia research 124 (1-3), 152-160, 2010 | 39 | 2010 |
| Treatment of early onset schizophrenia: recent trends, challenges and future considerations NS Vyas, N Gogtay Frontiers in psychiatry 3, 22227, 2012 | 38 | 2012 |
| What insights can we gain from studying early-onset schizophrenia? The neurodevelopmental pathway and beyond NS Vyas, S Kumra, BK Puri Expert review of neurotherapeutics 10 (8), 1243-1247, 2010 | 34 | 2010 |
| The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia NS Vyas, NH Patel, KS Nijran, A Al-Nahhas, BK Puri Expert Review of Neurotherapeutics 11 (1), 37-51, 2011 | 28 | 2011 |
| Evidence for an association between brain-derived neurotrophic factor Val66Met gene polymorphism and general intellectual ability in early-onset schizophrenia. NS Vyas, BK Puri The Israel journal of psychiatry and related sciences 49 (2), 137-142, 2012 | 18 | 2012 |
| D2/D3 dopamine receptor binding with [F-18] fallypride correlates of executive function in medication-naïve patients with schizophrenia NS Vyas, MS Buchsbaum, DS Lehrer, BM Merrill, A DeCastro, ... Schizophrenia research 192, 442-456, 2018 | 17 | 2018 |
| Association of KIBRA rs17070145 polymorphism with episodic memory in the early stages of a human neurodevelopmental disorder NS Vyas, K Ahn, DR Stahl, P Caviston, M Simic, S Netherwood, BK Puri, ... Psychiatry research 220 (1-2), 37-43, 2014 | 17 | 2014 |
| Association of a serotonin receptor 2A gene polymorphism with visual sustained attention in early-onset schizophrenia patients and their non-psychotic siblings NS Vyas, Y Lee, K Ahn, A Ternouth, DR Stahl, A Al-Chalabi, JF Powell, ... Aging and disease 3 (4), 291, 2012 | 17 | 2012 |
| Lack of gender influence on cortical and subcortical gray matter development in childhood-onset schizophrenia B Weisinger, D Greenstein, A Mattai, L Clasen, F Lalonde, S Feldman, ... Schizophrenia bulletin 39 (1), 52-58, 2013 | 16 | 2013 |
| Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia? NS Vyas, NH Patel, KS Nijran, A Al-Nahhas, BK Puri Nuclear Medicine Communications 31 (2), 91-93, 2010 | 16 | 2010 |
| Insights into schizophrenia using positron emission tomography: building the evidence and refining the focus NS Vyas, NH Patel, KS Nijran, A Al-Nahhas, BK Puri The British Journal of Psychiatry 197 (1), 3-4, 2010 | 13 | 2010 |
| Recent developments in neurochemical imaging in schizophrenia: an update N S Vyas, N H Patel, P Herscovitch, B K Puri, R Lanzenberger Current Medicinal Chemistry 20 (3), 351-356, 2013 | 11 | 2013 |
| Can genetics inform the management of cognitive deficits in schizophrenia? NS Vyas, SA Shamsi, AK Malhotra, KJ Aitchison, V Kumari Journal of Psychopharmacology 26 (3), 334-348, 2012 | 11 | 2012 |
Monte BuchsbaumUniversity of California, San DiegoVerified email at uci.edu
